id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-N-0476-0369,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Ross Herr (The Upjohn Company) and Dr. P. D. Lepore (FDA), dated 08/10/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:23:44Z,,0,0,0900006480521a72
FDA-1976-N-0476-0595,FDA,FDA-1976-N-0476,"Internal Memorandum from Staff Scientist Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305), October 06, 1981",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:21:22Z,,0,0,0900006480521b3d
FDA-1976-N-0476-0284,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. John Farnham, American Cyanamid Company and Dr. Carl Schulz, FDA/BVM, dated 10/04/1978",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:41:11Z,,0,0,0900006480521a1f
FDA-1976-N-0476-0275,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. Ir. P. van der Wal, ILOB and Drs. M. A. Norcross and P. D. Lepore, FDA/BVM, dated 12/16/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:37:27Z,,0,0,0900006480521a17
FDA-1976-N-0476-0316,FDA,FDA-1976-N-0476,Letter from National Association of Life Science Industries to FDA CVM,Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:12:26Z,,0,0,0900006480521a3e
FDA-1976-N-0476-0266,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. O. D. Butler and Dr. P. D. Lepore, FDA/BVM, dated 08/08/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:29:46Z,,0,0,0900006480521a10
FDA-1976-N-0476-0323,FDA,FDA-1976-N-0476,"Memorandum of Meeting between The Upjohn Company and FDA/BVM, dated 03/13/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:15:55Z,,0,0,0900006480521a44
FDA-1976-N-0476-0432,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Walter Gakenheimer (ICI America) and Dr. P. D. Lepore (FDA), dated 12/19/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T19:05:28Z,,0,0,0900006480521aaa
FDA-1976-N-0476-0404,FDA,FDA-1976-N-0476,"Memorandum of Meeting between The Upjohn Company and FDA, dated 10/16/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:54:27Z,,0,0,0900006480521a90
FDA-1976-N-0476-0394,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Patsy Marks (Dawson Laboratories) and Dr. Paul D. Lepore (FDA), dated 10/02/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:47:23Z,,0,0,0900006480521a88
FDA-1976-N-0476-0370,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Lowell Irminger (Adria) and Dr. P. D. Lepore (FDA), dated 08/29/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:23:45Z,,0,0,0900006480521a73
FDA-1976-N-0476-0399,FDA,FDA-1976-N-0476,Answer Letter from FDA to Xybion Medical Systems Corporation,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:47:45Z,,0,0,0900006483787852
FDA-1976-N-0476-0425,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. Paul D. Lepore (FDA), dated 11/30/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:59:47Z,,0,0,0900006480521aa4
FDA-1976-N-0476-0452,FDA,FDA-1976-N-0476,Answer Letter from FDA to EG&G Mason Research Institute,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:12:47Z,,0,0,090000648378c68f
FDA-1976-N-0476-0527,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Dr. William Gray (Schering Corporation) and Dr. P. D. Lepore (FDA/ORA) May 8 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:47:55Z,,0,0,0900006480521b03
FDA-1976-N-0476-0560,FDA,FDA-1976-N-0476,"Answer Letter from Dr. Paul D. Lepore, FDA to Robert S Gold, Metpath Inc",Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:59:28Z,,0,0,09000064837964ca
FDA-1976-N-0476-0555,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Patricia Richards (Fisonf Corporation) and Frank G. Pugliese (FDA/BVM), dated July 17 1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:56:26Z,,0,0,0900006480521b1c
FDA-1976-N-0476-0561,FDA,FDA-1976-N-0476,"Letter from Jean M Taylor, FDA to Ann Smith, Allied Chemical Company",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:00:08Z,,0,0,0900006480521b21
FDA-1976-N-0476-0528,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Donald Howard (G. D. Searle and Company) and Dr. P. D. Lepore (FDA/ORA), dated 05/12/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:47:56Z,,0,0,0900006480521b04
FDA-1976-N-0476-0601,FDA,FDA-1976-N-0476,Good Laboratory Practices for Nonclinical Laboratory Studies; Public Hearing,Notice,Hearings,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,1977-01-16T04:59:59Z,2019-01-30T21:21:54Z,76-36566,0,0,0900006480521b42
FDA-1976-N-0476-0563,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Dr. Fred Clark (A. H. Robins) and Dr. Paul D. Lepore (FDA/ORA) August 28 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:01:20Z,,0,0,0900006480521b23
FDA-1976-N-0476-0568,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Dr. Paul Gittleson (Bristol Labs) and Dr. Paul D. Lepore (FDA/ORA) October 28 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:02:43Z,,0,0,0900006480521b27
FDA-1976-N-0476-0503,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Nelson Ivans (Carter-Wallace Labs) and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:54Z,,0,0,0900006480521aec
FDA-1976-N-0476-0504,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between R. Holecek (Shell Development Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/18/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:55Z,,0,0,0900006480521aed
FDA-1976-N-0476-0483,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Virgil Place (Alza Corp) and Beth Anne Grove (FDA/BVM), dated 01/24/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:29:13Z,,0,0,0900006480521ad9
FDA-1976-N-0476-0524,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Don MacKellor (Toxigenics, Inc.) and Dr. P. D. Lepore (FDA/ORA) April 18 1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:45:04Z,,0,0,0900006480521b01
FDA-1976-N-0476-0419,FDA,FDA-1976-N-0476,"Internal Memorandum from Steven S. Kuwahara, Bureau of Disease Control and Laboratory Services State of Michigan and Paul W. Goebel, Jr. (HFB-730) November 1, 1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:59:40Z,,0,0,0900006480521a9e
FDA-1976-N-0476-0373,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Max Moeller (Bayvet Corporation) and Dr. Paul Lepore (FDA), dated 08/30/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:32:37Z,,0,0,0900006480521a75
FDA-1976-N-0476-0351,FDA,FDA-1976-N-0476,Petition for Stay of Action from The Pharmaceutical Manufacturers Association,Other,Petition for Reconsideration,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:55:05Z,,0,0,0900006480521a61
FDA-1976-N-0476-0352,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. W. Gakenheimer, ICI Americas and Dr. Paul D. Lepore, FDA dated 06/21/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:55:06Z,,0,0,0900006480521a62
FDA-1976-N-0476-0360,FDA,FDA-1976-N-0476,Answer Letter from FDA to Objection from Dennis McKay,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:14:33Z,,0,0,0900006483785c91
FDA-1976-N-0476-0303,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. T. S. Grafton, Natl. Soc. for Med. Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:54:28Z,,0,0,0900006480521a32
FDA-1976-N-0476-0307,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Leroy Schilt, Ralston Purina and Dr. P. D. Lepore, FDA/BVM dated 01/18/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:00:20Z,,0,0,0900006480521a36
FDA-1976-N-0476-0321,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Drs. H. M. Peck and R. T. Drew, Merck Sharp & Dohme and Drs. D. Wagner and P. D. Lepore, FDA/BVM dated 03/08/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:15:52Z,,0,0,0900006480521a42
FDA-1976-N-0476-0319,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Ralston Purina Co. and FDA/BVM, dated 02/07/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:15:49Z,,0,0,0900006480521a40
FDA-1976-N-0476-0333,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Cynthia Sargent, Lederle Labs and Dr. P. D. Lepore, FDA dated 04/28/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:43:40Z,,0,0,0900006480521a4f
FDA-1976-N-0476-0480,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Don McKuellar (Toxigenics, Inc) and Dr. P. D. Lepore (FDA/ORA), dated 01/30/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:25:22Z,,0,0,0900006480521ad6
FDA-1976-N-0476-0556,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Sheldon Mazursky (Litton Bionetics) and Dr. Paul D. Lepore (FDA/ORA) July 25 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:56:27Z,,0,0,0900006480521b1d
FDA-1976-N-0476-0502,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Julian Kramer and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:53Z,,0,0,0900006480521aeb
FDA-1976-N-0476-0469,FDA,FDA-1976-N-0476,Supplement from Pharmaceutical Manufacturers Association,Other,Supplement (SUP),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:25:11Z,,0,0,0900006480521aca
FDA-1976-N-0476-0574,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Dr. Jim Schaefer (Elars Bioresearch) and Dr. Paul D. Lepore (FDA) December 22 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:02:50Z,,0,0,0900006480521b2d
FDA-1976-N-0476-0564,FDA,FDA-1976-N-0476,Memorandum of Meeting between The Upjohn Company and FDA/ORA September 17 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:01:21Z,,0,0,0900006480521b24
FDA-1976-N-0476-0565,FDA,FDA-1976-N-0476,Memorandum of Meeting between Jonas Bassen and Dr. P. D. Lepore (FDA/ORA) October 7 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:01:22Z,,0,0,0900006480521b25
FDA-1976-N-0476-0341,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. M. Lovell, Lederle Laboratories and Dr. P. D. Lepore, FDA dated 05/22/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:45:43Z,,0,0,0900006480521a57
FDA-1976-N-0476-0602,FDA,FDA-1976-N-0476,"Good Laboratory Practices for Nonclinical laboratory Studies, Public Hearing Extension",Notice,Hearings,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2020-01-31T06:56:46Z,77-3217,0,0,0900006483786fa1
FDA-1976-N-0476-0291,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David D. Wagner, FDA/BVM dated 01/15/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:42:57Z,,0,0,0900006480521a26
FDA-1976-N-0476-0273,FDA,FDA-1976-N-0476,"Memorandum of Meeting between A. Fozard and A. Nelms, Mount Industrial Estate and M. A. Norcross and P. D. Lepore FDA/BVM dated 11/11/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:35:45Z,,0,0,0900006480521a15
FDA-1976-N-0476-0279,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. Benjamin H. Franklin, Dow Corning Corporation and Dr. Carl O Schulz, FDA/BVM, dated 06/01/1978",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:39:51Z,,0,0,0900006480521a1a
FDA-1976-N-0476-0280,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. George Schuppler, Dept. of Experimental Toxicology, and Drs. Paul Lepore et. al. FDA/BVM, dated 05/17/1978",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:39:52Z,,0,0,0900006480521a1b
FDA-1976-N-0476-0309,FDA,FDA-1976-N-0476,Answer Letter from FDA to Objection from Dr. Travis Griffin,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:00:28Z,,0,0,090000648377a46e
FDA-1976-N-0476-0312,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Alan Hirsh, Ortho Pharmaceutical Corp. and Dr. P. D. Lepore, FDA/BVM dated 01/26/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:12:22Z,,0,0,0900006480521a3a
FDA-1976-N-0476-0302,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Ms. Marion Vinegar, Hilltop Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:54:27Z,,0,0,0900006480521a31
FDA-1976-N-0476-0249,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Richard Morey, Kleinfeld, Kaplan, and Becker and Howard R. Roberts, FDA dated 04/12/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:23:32Z,,0,0,0900006480521a02
FDA-1976-N-0476-0324,FDA,FDA-1976-N-0476,"Nonclinical Laboratory Studies, Good Laboratory Practice Regulations; Correction",Rule,Correction,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:15:55Z,79-9094,0,0,0900006480521a45
FDA-1976-N-0476-0322,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between T. J. Fogg, Shell and Dr. P. D. Lepore, FDA/BVM dated 03/12/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:15:53Z,,0,0,0900006480521a43
FDA-1976-N-0476-0429,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Eva Zurek (Hazleton Laboratories) and Dr. P. D. Lepore (FDA), dated 12/11/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T19:02:08Z,,0,0,0900006480521aa7
FDA-1976-N-0476-0363,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. R. Drew (Merck & Company) and Dr. P. D. Lepore (FDA), dated 08/03/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:18:32Z,,0,0,0900006480521a6c
FDA-1976-N-0476-0401,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Nona Karten (Mason Research Institute) and Dr. P. D. Lepore (FDA), dated 10/11/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:52:30Z,,0,0,0900006480521a8d
FDA-1976-N-0476-0248,FDA,FDA-1976-N-0476,"Answer Letter from FDA to Comment from Honorable Wendell R. Anderson, United States Senate",Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:14:01Z,,0,0,090000648374730d
FDA-1976-N-0476-0539,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Hall Moore (Burroughs-Wellcome) and Dr. P. D. Lepore (FDA/ORA) May 30 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:50:13Z,,0,0,0900006480521b0e
FDA-1976-N-0476-0590,FDA,FDA-1976-N-0476,Answer Letter from FDA to Bundesverband Der Pharmazeutischen Industrie E. V.,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:12:10Z,,0,0,09000064837998a2
FDA-1976-N-0476-0598,FDA,FDA-1976-N-0476,Memorandum of Meeting between The Upjohn Company and FDA/ORA February 22 1982,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:21:25Z,,0,0,0900006480521b40
FDA-1976-N-0476-0576,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. Thomas W. Orme (Toxicology Paperwork and Information, Inc.) and Dr. Paul D. Lepore (FDA) February 10 1981",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:02:52Z,,0,0,0900006480521b2f
FDA-1976-N-0476-0505,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Art Uelner (Monsanto Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/21/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:56Z,,0,0,0900006480521aee
FDA-1976-N-0476-0345,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. E. C. Sadero, Intermedics and Dr. P. D. Lepore, FDA dated 06/05/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:45:47Z,,0,0,0900006480521a5b
FDA-1976-N-0476-0338,FDA,FDA-1976-N-0476,"Internal Memorandum from Biological Scientist, Bioresearch Monitoring Staff (HFC-30) to Director Division of Field Investigations (HF0-500) May 21, 1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:45:40Z,,0,0,0900006480521a54
FDA-1976-N-0476-0254,FDA,FDA-1976-N-0476,"Memorandum from James A. Peters, Division of Cancer Cause & Prevention, NCI to Associate Commissioner for Science, FDA",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:26:43Z,,0,0,0900006480521a06
FDA-1976-N-0476-0311,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Ms. Laurie Ennis, Seller, Conner, & Cuneo and Dr. P. D. Lepore, FDA/BVM dated 01/29/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:12:21Z,,0,0,0900006480521a39
FDA-1976-N-0476-0310,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Mr. Mike Hurley, Ayerst Laboratories and Dr. P. D. Lepore, FDA/BVM dated 01/23/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:12:20Z,,0,0,0900006480521a38
FDA-1976-N-0476-0331,FDA,FDA-1976-N-0476,Good Laboratory Practices Management Conferences Public Meeting,Notice,General Notice,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T17:41:31Z,,0,0,0900006480521a4b
FDA-1976-N-0476-0551,FDA,FDA-1976-N-0476,"Letter from Nadine Drennan, Sanitation Laboratories to Paul D. Lepore, FDA",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:54:18Z,,0,0,0900006480521b19
FDA-1976-N-0476-0535,FDA,FDA-1976-N-0476,"Letter from Ernest Brisson, FDA to Jose C. March, Guerlain, Inc.",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:49:00Z,,0,0,0900006480521b0b
FDA-1976-N-0476-0523,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between ICI America and FDA/ORA April 18 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:45:03Z,,0,0,0900006480521b00
FDA-1976-N-0476-0546,FDA,FDA-1976-N-0476,Answer Letter from FDA to H. Lundbeck & Co.,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:52:11Z,,0,0,09000064837953e4
FDA-1976-N-0476-0493,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. William D. Grey (Schering-Plough Corporation) and Dr. Paul D. Lepore (FDA/ORA), dated 02/25/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:45Z,,0,0,0900006480521ae2
FDA-1976-N-0476-0497,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Dr. Lee Caldwell (G. D. Searle & Co.) and Dr. P. D. Lepore (FDA/ORA) dated 03/03/1980 and 03/04/1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:36:49Z,,0,0,0900006480521ae6
FDA-1976-N-0476-0562,FDA,FDA-1976-N-0476,Letter from Dr. Paul D. Lepore to John J Gagliardi,Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:01:19Z,,0,0,0900006480521b22
FDA-1976-N-0476-0592,FDA,FDA-1976-N-0476,"Internal Memorandum from Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305) June 19, 1981",Supporting & Related Material,Reference (internal unless indicated),2019-01-30T05:00:00Z,2019,1,,,2019-01-30T21:12:48Z,,0,0,0900006480521b3a
FDA-1976-N-0476-0400,FDA,FDA-1976-N-0476,Answer from FDA to Letter from American Cyanimid Company,Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:49:36Z,,0,0,090000648378567d
FDA-1976-N-0476-0412,FDA,FDA-1976-N-0476,"Letter from Larry S. Isacson of Beckman Instruments, Inc. to Paul Lepore of FDA",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:56:26Z,,0,0,0900006480521a98
FDA-1976-N-0476-0423,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. P. D. Lepore (FDA), dated 11/28/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:59:45Z,,0,0,0900006480521aa2
FDA-1976-N-0476-0417,FDA,FDA-1976-N-0476,Letter from Carnegie-Mellon Institute of Research to FDA,Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:58:23Z,,0,0,0900006480521a9c
FDA-1976-N-0476-0377,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Nelson Ivins (09/07/1979) and Dr. P. D. Lepore (FDA), dated 09/07/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:32:40Z,,0,0,0900006480521a79
FDA-1976-N-0476-0375,FDA,FDA-1976-N-0476,Letter from FDA to Borriston Research Laboratories,Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:32:39Z,,0,0,0900006480521a77
FDA-1976-N-0476-0371,FDA,FDA-1976-N-0476,"Letter from Microscopy for Biological Research, Ltd. to FDA",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:23:46Z,,0,0,0900006480521a74
FDA-1976-N-0476-0361,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Charles Rayner (Miles Laboratories) and Dr. P. D. Lepore (FDA), dated 07/12/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T18:18:30Z,,0,0,0900006480521a6a
FDA-1976-N-0476-0451,FDA,FDA-1976-N-0476,Letter from EG. and G. Mason Research Institute to FDA,Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:10:00Z,,0,0,0900006480521aba
FDA-1976-N-0476-0437,FDA,FDA-1976-N-0476,"Letter from Paul D. Lepore, FDA to Robert Broyles, Ralston-Purina Company",Other,Letter(s),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T19:07:11Z,,0,0,0900006480521aae
FDA-1976-N-0476-0257,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Drs. Sanford Berman and Dr. Howard Lowensohn, Walter Reed Institute of Research and Dr. P. D. Lepore FDA/CVM dated 06/16/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:26:46Z,,0,0,0900006480521a09
FDA-1976-N-0476-0265,FDA,FDA-1976-N-0476,"Memorandum of Meeting Between ICI USA, ICI UK and FDA BVM, dated 07/07/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:29:45Z,,0,0,0900006480521a0f
FDA-1976-N-0476-0288,FDA,FDA-1976-N-0476,"Memorandum from Paul D. Lepore, FDA/BVM to Dr. L. Schilt, Ralston Purina",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:42:55Z,,0,0,0900006480521a23
FDA-1976-N-0476-0269,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Dr. Erwig Pinter, BPI and Drs. Paul D. Lepore and Carl O. Schulz FDA/BVM, dated 09/20/1977",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:31:49Z,,0,0,0900006480521a12
FDA-1976-N-0476-0298,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Paul Kraus, Allergan and Dr. P. D. Lepore, FDA/BVM dated 01/03/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:54:22Z,,0,0,0900006480521a2d
FDA-1976-N-0476-0294,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Mr. Mike McCulley, Am. Hospital Supply Company and Dr. P. D. Lepore, FDA/BVM dated 01/05/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:43:00Z,,0,0,0900006480521a29
FDA-1976-N-0476-0315,FDA,FDA-1976-N-0476,"Memorandum of Meeting between Allied Mills, Inc. and FDA/BVM dated 02/16/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T15:12:25Z,,0,0,0900006480521a3d
FDA-1976-N-0476-0289,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David Wagner, FDA/BVM dated 01/08/1979",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T14:42:56Z,,0,0,0900006480521a24
FDA-1976-N-0476-0594,FDA,FDA-1976-N-0476,"Internal Memorandum from Dr. Paul D. Lepore (HFC-30) to Dockets Management Branch (HFA-305), August 14,1981",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T21:21:21Z,,0,0,0900006480521b3c
FDA-1976-N-0476-0487,FDA,FDA-1976-N-0476,"Memorandum of Telephone Conversation between Dr. Jim Richmond (Ciba-Geigy) and Dr. Paul D. Lepore (FDA/ORA), dated 02/07/1980",Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:29:16Z,,0,0,0900006480521add
FDA-1976-N-0476-0552,FDA,FDA-1976-N-0476,"Answer Letter from Paul D. Lepore, FDA to Nadine Drennan, Sanitation Laboratories",Other,Answer,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:55:00Z,,0,0,0900006483795bec
FDA-1976-N-0476-0518,FDA,FDA-1976-N-0476,Memorandum of Telephone Conversation between Huntingdon Research Centre and FAD/ORA April 28 1980,Other,Memorandum,2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,,2019-01-30T20:44:59Z,,0,0,0900006480521afb